546 related articles for article (PubMed ID: 30037330)
1. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-876-5p represses the cell proliferation and invasion of colorectal cancer through suppressing YAP signalling via targeting RASAL2.
Ren L; Zhang Z; Feng Y; Luo M; Hao Z
Clin Exp Pharmacol Physiol; 2020 May; 47(5):867-876. PubMed ID: 31990059
[TBL] [Abstract][Full Text] [Related]
3. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
Sun Z; Zhang Q; Yuan W; Li X; Chen C; Guo Y; Shao B; Dang Q; Zhou Q; Wang Q; Wang G; Liu J; Kan Q
J Exp Clin Cancer Res; 2020 Nov; 39(1):250. PubMed ID: 33218358
[TBL] [Abstract][Full Text] [Related]
4. EXOSC4 functions as a potential oncogene in development and progression of colorectal cancer.
Pan Y; Tong JHM; Kang W; Lung RWM; Chak WP; Chung LY; Wu F; Li H; Yu J; Chan AWH; To KF
Mol Carcinog; 2018 Dec; 57(12):1780-1791. PubMed ID: 30155936
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
6. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
[TBL] [Abstract][Full Text] [Related]
7. Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.
Yu M; Cui R; Huang Y; Luo Y; Qin S; Zhong M
EBioMedicine; 2019 Oct; 48():264-276. PubMed ID: 31530502
[TBL] [Abstract][Full Text] [Related]
8. CADM1 associates with Hippo pathway core kinases; membranous co-expression of CADM1 and LATS2 in lung tumors predicts good prognosis.
Ito T; Nakamura A; Tanaka I; Tsuboi Y; Morikawa T; Nakajima J; Takai D; Fukayama M; Sekido Y; Niki T; Matsubara D; Murakami Y
Cancer Sci; 2019 Jul; 110(7):2284-2295. PubMed ID: 31069869
[TBL] [Abstract][Full Text] [Related]
9. Expression of hippo pathway in colorectal cancer.
Liang K; Zhou G; Zhang Q; Li J; Zhang C
Saudi J Gastroenterol; 2014; 20(3):188-94. PubMed ID: 24976283
[TBL] [Abstract][Full Text] [Related]
10. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
Qian F; Xiao J; Gai L; Zhu J
Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
[TBL] [Abstract][Full Text] [Related]
11. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
Peng H; Pan X; Su Q; Zhu LS; Ma GD
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
[TBL] [Abstract][Full Text] [Related]
12. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
14. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization.
Chen C; Yuan W; Zhou Q; Shao B; Guo Y; Wang W; Yang S; Guo Y; Zhao L; Dang Q; Yang X; Wang G; Kang Q; Ji Z; Liu J; Sun Z
Theranostics; 2021; 11(9):4298-4315. PubMed ID: 33754062
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
Zhong X; Lü M; Wan J; Zhou T; Qin B
Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
[TBL] [Abstract][Full Text] [Related]
16. Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR-942-5p and releasing DLG2 via Hippo-YAP signaling.
Li S; Yan G; Liu W; Li C; Wang X
Mol Carcinog; 2020 Dec; 59(12):1323-1342. PubMed ID: 33128289
[TBL] [Abstract][Full Text] [Related]
17. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer.
Sun Z; Ou C; Liu J; Chen C; Zhou Q; Yang S; Li G; Wang G; Song J; Li Z; Zhang Z; Yuan W; Li X
Oncogene; 2019 Apr; 38(14):2627-2644. PubMed ID: 30531836
[TBL] [Abstract][Full Text] [Related]
18. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.
Feng S; Sun H; Zhu W
Clin Transl Oncol; 2021 Mar; 23(3):450-458. PubMed ID: 32654106
[TBL] [Abstract][Full Text] [Related]
19. IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation.
Zhang W; Lu Y; Li X; Zhang J; Lin W; Zhang W; Zheng L; Li X
J Exp Clin Cancer Res; 2019 Jul; 38(1):296. PubMed ID: 31288861
[TBL] [Abstract][Full Text] [Related]
20. Loss of HACE1 promotes colorectal cancer cell migration via upregulation of YAP1.
Zhou Z; Zhang HS; Zhang ZG; Sun HL; Liu HY; Gou XM; Yu XY; Huang YH
J Cell Physiol; 2019 Jun; 234(6):9663-9672. PubMed ID: 30362561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
